Vinay Prasad has stepped down as head of the FDA's Center for Biologics Evaluation and Research (CBER), less than three months after taking on the role. His departure – first reported by STAT and now ...
CDER director George Tidmarsh will now also take responsibility for CBER at the FDA. The FDA has moved swiftly to fill the void left by Vinay Prasad's resignation as director of the Center for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results